EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis

Thuong Trinh-Minh, Chih-Wei Chen, Cuong Tran Manh, Yi-Nan Li, Honglin Zhu, Xiang Zhou, Debomita Chakraborty, Yun Zhang, Simon Rauber, Clara Dees, Neng-Yu Lin, Delf Kah und 12 weitere

Journal of Clinical Investigation · 15.05.2024 · 134 (10)

DOI: 10.1172/jci159884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 26.03.2024. Verfasst von Thuong Trinh-Minh und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and. Hauptthemen laut MEDLINE: Fibroblasts, Myofibroblasts, Transforming Growth Factor beta, Wnt-5a Protein. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Interdisziplinäre Zentrum für Klinische Forschung - Erlangen, Wilhelm Sander-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transforming growth factor β (TGF-β) signaling is a core pathway of fibrosis, but the molecular regulation of the activation of latent TGF-β remains incompletely understood. Here, we demonstrate a crucial role of WNT5A/JNK/ROCK signaling that rapidly coordinates the activation of latent TGF-β in fibrotic diseases. WNT5A was identified as a predominant noncanonical WNT ligand in fibrotic diseases such as systemic sclerosis, sclerodermatous chronic graft-versus-host disease, and idiopathic pulmonary fibrosis, stimulating fibroblast-to-myofibroblast transition and tissue fibrosis by activation of latent TGF-β. The activation of latent TGF-β requires rapid JNK- and ROCK-dependent cytoskeletal rearrangements and integrin α V (ITGAV). Conditional ablation of WNT5A or its downstream targets prevented activation of latent TGF-β, rebalanced TGF-β signaling, and ameliorated experimental fibrosis. We thus uncovered what we believe to be a novel mechanism for the aberrant activation of latent TGF-β in fibrotic diseases and provided evidence for targeting WNT5A/JNK/ROCK signaling in fibrotic diseases as a new therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsMyofibroblastsTransforming Growth Factor betaWnt-5a ProteinCell TransdifferentiationFibrosisScleroderma, SystemicGraft vs Host DiseaseIdiopathic Pulmonary FibrosisMAP Kinase Kinase 4rho-Associated KinasesLigandsSkinHumansAnimalsMiceCells, CulturedUp-Regulation

Stichwörter der Autor:innen

DermatologyFibrosisPulmonology

Substanzen

Transforming Growth Factor betaWnt-5a ProteinMAP Kinase Kinase 4rho-Associated KinasesLigands

Autor:innen und Institutionen

  • Department of Rheumatology and.
  • Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, North-Rhine-Westphalia, Germany.
  • Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Bavaria, Germany.
  • German Center for Immunotherapy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University of Erlangen, Erlangen, Bavaria, Germany.
  • Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
  • Graduate Institute of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Interdisziplinäre Zentrum für Klinische Forschung - Erlangen
  • Wilhelm Sander-Stiftung
  • Else Kröner-Fresenius-Stiftung
  • ELAN-Foundation Erlangen

Zitieren

APA

Trinh-Minh, T., Chen, C. W., Tran Manh, C., Li, Y. N., Zhu, H., Zhou, X., Chakraborty, D., Zhang, Y., Rauber, S., Dees, C., Lin, N. Y., Kah, D., Gerum, R., Bergmann, C., Kreuter, A., Reuter, C., Groeber-Becker, F., Eckes, B., Distler, O., …, & Distler, J. H. (2024). Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis. Journal of Clinical Investigation, 134(10). https://doi.org/10.1172/jci159884

Vancouver

Trinh-Minh T, Chen CW, Tran Manh C, Li YN, Zhu H, Zhou X, et al. Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis. Journal of Clinical Investigation. 2024;134(10). doi:10.1172/jci159884

BibTeX
@article{TrinhMinh2024,
  author = {Trinh-Minh, Thuong and Chen, Chih-Wei and Tran Manh, Cuong and Li, Yi-Nan and Zhu, Honglin and Zhou, Xiang and Chakraborty, Debomita and Zhang, Yun and Rauber, Simon and Dees, Clara and Lin, Neng-Yu and Kah, Delf and Gerum, Richard and Bergmann, Christina and Kreuter, Alexander and Reuter, Christiane and Groeber-Becker, Florian and Eckes, Beate and Distler, Oliver and Fabry, Ben and Ramming, Andreas and Schambony, Alexandra and Schett, Georg and Distler, Jörg Hw},
  title = {Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {10},
  doi = {10.1172/jci159884}
}
Kostenlos starten →